These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38096965)

  • 1. The role and mechanism of AZD5363 anti-leukemia activity in T-cell acute lymphoblastic leukemia.
    Luo D; Li S; Guo J; Yue H; Shi L; Liu R; Wang J; Shi X
    Eur J Pharmacol; 2024 Jan; 963():176268. PubMed ID: 38096965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol induces apoptosis and autophagy in T-cell acute lymphoblastic leukemia cells by inhibiting Akt/mTOR and activating p38-MAPK.
    Ge J; Liu Y; Li Q; Guo X; Gu L; Ma ZG; Zhu YP
    Biomed Environ Sci; 2013 Nov; 26(11):902-11. PubMed ID: 24331535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia.
    Alameen AA; Simioni C; Martelli AM; Zauli G; Ultimo S; McCubrey JA; Gonelli A; Marisi G; Ulivi P; Capitani S; Neri LM
    Oncotarget; 2016 Aug; 7(34):55690-55703. PubMed ID: 27494886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted delivery of AZD5363 to T-cell acute lymphocytic leukemia by mSiO
    Yang A; Luo D; Jia Y; Liu Y; Zhang Z; Li S; Liu R; Zhou J; Wang J
    Colloids Surf B Biointerfaces; 2023 Oct; 230():113505. PubMed ID: 37574619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carvedilol exhibits anti-acute T lymphoblastic leukemia effect in vitro and in vivo via inhibiting β-ARs signaling pathway.
    Xu Y; Li J; Luo Y; Ma J; Huang P; Chen Y; He Z
    Biochem Biophys Res Commun; 2023 Jan; 639():150-160. PubMed ID: 36495764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marsdenia tenacissimae extraction (MTE) inhibits the proliferation and induces the apoptosis of human acute T cell leukemia cells through inactivating PI3K/AKT/mTOR signaling pathway via PTEN enhancement.
    Wang Y; Chen B; Wang Z; Zhang W; Hao K; Chen Y; Li K; Wang T; Xie Y; Huang Z; Tong X
    Oncotarget; 2016 Dec; 7(50):82851-82863. PubMed ID: 27756877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of FAPP2 gene induces cell autophagy and inhibits PI3K/AKT/mTOR pathway in T-cell acute lymphoblastic leukemia.
    Yuan T; Wang J; Shi C; Wang Y; Xia B; Xu W; Yang H; Yang Y; Ye MT; Khalid S; Liang Y; Tian C; You MJ; Wang Y
    Hematol Oncol; 2022 Apr; 40(2):249-257. PubMed ID: 34796518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetrandrine and cepharanthine induce apoptosis through caspase cascade regulation, cell cycle arrest, MAPK activation and PI3K/Akt/mTOR signal modification in glucocorticoid resistant human leukemia Jurkat T cells.
    Xu W; Wang X; Tu Y; Masaki H; Tanaka S; Onda K; Sugiyama K; Yamada H; Hirano T
    Chem Biol Interact; 2019 Sep; 310():108726. PubMed ID: 31255635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia.
    Cani A; Simioni C; Martelli AM; Zauli G; Tabellini G; Ultimo S; McCubrey JA; Capitani S; Neri LM
    Oncotarget; 2015 Mar; 6(9):6597-610. PubMed ID: 25788264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The depletion of Circ-PRKDC enhances autophagy and apoptosis in T-cell acute lymphoblastic leukemia via microRNA-653-5p/Reelin mediation of the PI3K/AKT/mTOR signaling pathway.
    Ling Z; Fang ZG; Wu JY; Liu JJ
    Kaohsiung J Med Sci; 2021 May; 37(5):392-401. PubMed ID: 33615686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination Effect of Notch1 and PI3K/AKT/mTOR Signaling Pathways Inhibitors on T-ALL Cell Lines.
    Khoshamooz H; Kaviani S; Atashi A; Mirpour Hassankiadeh SH
    Int J Hematol Oncol Stem Cell Res; 2020 Apr; 14(2):99-109. PubMed ID: 32461793
    [No Abstract]   [Full Text] [Related]  

  • 12. Dual inhibition of class IA phosphatidylinositol 3-kinase and mammalian target of rapamycin as a new therapeutic option for T-cell acute lymphoblastic leukemia.
    Chiarini F; Falà F; Tazzari PL; Ricci F; Astolfi A; Pession A; Pagliaro P; McCubrey JA; Martelli AM
    Cancer Res; 2009 Apr; 69(8):3520-8. PubMed ID: 19351820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway.
    Lonetti A; Cappellini A; Bertaina A; Locatelli F; Pession A; Buontempo F; Evangelisti C; Evangelisti C; Orsini E; Zambonin L; Neri LM; Martelli AM; Chiarini F
    J Hematol Oncol; 2016 Oct; 9(1):114. PubMed ID: 27776559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of Autophagy Can Augment PIK3 Inhibitor Induced Apoptosis in T Lymphoblastic Leukemia Cell Lines.
    Dong YQ; Sun N; Yang XC; He MQ; Huang H; Guo WJ; Lin XJ
    Ann Clin Lab Sci; 2023 Jul; 53(4):598-606. PubMed ID: 37625845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Andrographolide inhibits growth of human T-cell acute lymphoblastic leukemia Jurkat cells by downregulation of PI3K/AKT and upregulation of p38 MAPK pathways.
    Yang T; Yao S; Zhang X; Guo Y
    Drug Des Devel Ther; 2016; 10():1389-97. PubMed ID: 27114702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sam68 affects cell proliferation and apoptosis of human adult T-acute lymphoblastic leukemia cells via AKT/mTOR signal pathway.
    Wang Q; Li Y; Cheng J; Chen L; Xu H; Li Q; Pang T
    Leuk Res; 2016 Jul; 46():1-9. PubMed ID: 27107742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timosaponin A‑III induces autophagy of T‑cell acute lymphoblastic leukemia Jurkat cells via inhibition of the PI3K/Akt/mTOR pathway.
    Wang H; Dong R; Fan WW; Zheng XC; Li AM; Wang WD
    Oncol Rep; 2019 May; 41(5):2937-2944. PubMed ID: 30896824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyphyllin I Promoted Melanoma Cells Autophagy and Apoptosis via PI3K/Akt/mTOR Signaling Pathway.
    Long J; Pi X
    Biomed Res Int; 2020; 2020():5149417. PubMed ID: 32733943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation.
    Fox EM; Kuba MG; Miller TW; Davies BR; Arteaga CL
    Breast Cancer Res; 2013; 15(4):R55. PubMed ID: 23844554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AKT Antagonist AZD5363 Influences Estrogen Receptor Function in Endocrine-Resistant Breast Cancer and Synergizes with Fulvestrant (ICI182780) In Vivo.
    Ribas R; Pancholi S; Guest SK; Marangoni E; Gao Q; Thuleau A; Simigdala N; Polanska UM; Campbell H; Rani A; Liccardi G; Johnston S; Davies BR; Dowsett M; Martin LA
    Mol Cancer Ther; 2015 Sep; 14(9):2035-48. PubMed ID: 26116361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.